| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/31/2000 | EP1003740A2 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists |
| 05/31/2000 | EP1003737A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists |
| 05/31/2000 | EP1003721A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases |
| 05/31/2000 | EP1003509A1 Il-8 receptor antagonists |
| 05/31/2000 | EP1003507A1 Combination therapy comprising amlodipine and a statin compound |
| 05/31/2000 | EP1003503A1 Therapeutic combinations comprising amlodipin and atorvastatin |
| 05/31/2000 | EP1003497A1 Il-8 receptor antagonists |
| 05/31/2000 | EP1003481A1 Fibrinogen-coated microspheres |
| 05/31/2000 | EP0983105A4 Method of removing thrombosis in fistulae |
| 05/31/2000 | EP0944650B1 Antithrombotic peptides derived from fibronectin type ii repeats |
| 05/31/2000 | DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs |
| 05/31/2000 | CN1254597A Antiswelling medicine |
| 05/31/2000 | CN1052900C Antisepsis, anti-inflammation and hemostasis capsules |
| 05/30/2000 | US6069254 Carboxamide derivatives of piperidine for the treatment of thrombosis disorders |
| 05/30/2000 | US6069234 Factor xa containing epidermal growth factor-like domains and with its light protein chain truncated at n- and c-terminals; for use in crystallographic inhibition studies for designing new anticoagulants |
| 05/30/2000 | US6069232 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 05/30/2000 | US6069143 Anticoagulants |
| 05/30/2000 | US6069139 Method and composition for prophulaxis and treatment of retinal diseases |
| 05/30/2000 | US6069130 Prodrugs useful in vivo or invitro for preventing or treating coagulation disorders |
| 05/30/2000 | US6069129 Elastin derived composition and method of using same |
| 05/30/2000 | US6068838 Purified multimerase having proteolytic activity, converts von willebrand factor having a singlet structure to von willebrand factor having satellite structure and is active in presence of serine protease and calpin protease inhibitor |
| 05/30/2000 | CA2181566C Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 05/25/2000 | WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029422A1 31 human secreted proteins |
| 05/25/2000 | WO2000029407A1 Isoxazoline fibrinogen receptor antagonists |
| 05/25/2000 | WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 05/25/2000 | WO2000029378A2 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 05/25/2000 | WO2000029029A1 Compositions and methods for producing vascular occlusion |
| 05/25/2000 | WO2000029019A1 Restoration of platelet aggregation by antibody administration after gpiib/iiia antagonist treatment |
| 05/25/2000 | WO2000029014A1 Method of treating heparin-induced thrombocytopenia |
| 05/25/2000 | WO2000028987A1 Methods of treating thrombocytopenia |
| 05/25/2000 | WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 05/25/2000 | WO2000012049A3 A method for the treatment of staphylococcal disease |
| 05/25/2000 | WO1999026644A9 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 05/25/2000 | WO1998049350A8 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes |
| 05/25/2000 | DE19853487A1 Use of dialkyl fumarate for treating transplant rejection and autoimmune disease |
| 05/25/2000 | CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | CA2351067A1 Method of treating heparin-induced thrombocytopenia |
| 05/25/2000 | CA2350785A1 31 human secreted proteins |
| 05/25/2000 | CA2350742A1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348781A1 Compositions and methods for producing vascular occlusion |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | CA2345342A1 Isoxazoline fibrinogen receptor antagonists |
| 05/24/2000 | EP1002544A1 Anti-edema agent |
| 05/24/2000 | EP1002106A1 Production and use of recombinant protein multimers with altered biological activity |
| 05/24/2000 | EP1002083A1 Aprotinin variants with improved properties and bikunins of aprotinin variants |
| 05/24/2000 | EP1002074A1 Calcium-binding phosphoprotein |
| 05/24/2000 | EP1001979A1 Cyclic azapeptides with angiogenic effect |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001965A1 Tissue plasminogen activator-like protease |
| 05/24/2000 | EP1001795A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 05/24/2000 | EP1001777A1 Fibrinogen receptor antagonists |
| 05/24/2000 | EP1001755A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/24/2000 | EP1001675A1 Platelet suspensions and methods for resuspending platelets |
| 05/24/2000 | EP0720620B1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 05/24/2000 | EP0529031B1 Improved inhibitors of thrombin |
| 05/24/2000 | CN1254345A Serine protease inhibitors |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/24/2000 | CN1254335A Nicotinamide derivatives |
| 05/24/2000 | CN1254284A Activated protein C formulations |
| 05/24/2000 | CN1254255A Methods for reducing fibrinogen |
| 05/24/2000 | CN1253948A Substituted tricyclic compound |
| 05/24/2000 | CN1052644C Medicine for curing strip scleroma of thrombophlebitis |
| 05/24/2000 | CN1052640C Pills replenishing bone marrow |
| 05/23/2000 | US6066642 For selectively blocking the a3 adenosine receptor of a mammal |
| 05/23/2000 | US6066317 Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells |
| 05/18/2000 | WO2000028029A2 Cell surface glycoproteins |
| 05/18/2000 | WO2000028023A2 Ischaemia/reperfusion-inducible dna's and proteins |
| 05/18/2000 | WO2000028004A1 Virus vectors and methods of making and administering the same |
| 05/18/2000 | WO2000027998A2 Method and compositions for improving allogeneic hematopoietic cell transplantation |
| 05/18/2000 | WO2000027845A1 Spiro-indolines as y5 receptor antagonists |
| 05/18/2000 | WO2000027822A2 Tricyclic pyrazole derivatives |
| 05/18/2000 | WO2000027425A2 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 05/18/2000 | WO2000027414A2 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | WO2000027409A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 05/18/2000 | WO2000027394A1 Activators of soluble guanylate cyclase |
| 05/18/2000 | WO2000027378A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | WO2000027359A1 An inhalation system |
| 05/18/2000 | WO2000027327A1 Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| 05/18/2000 | WO2000027199A1 Aminobenzisoxazole compounds and libraries thereof |
| 05/18/2000 | CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine |
| 05/18/2000 | CA2350714A1 Spiro-indolines as y5 receptor antagonists |
| 05/18/2000 | CA2350628A1 Hemostatic polymer useful for rapid blood coagulation and hemostasis |
| 05/18/2000 | CA2350235A1 Tricyclic pyrazole derivatives |
| 05/18/2000 | CA2349644A1 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 05/18/2000 | CA2349449A1 Cell surface glycoproteins |
| 05/18/2000 | CA2348946A1 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same |
| 05/18/2000 | CA2347916A1 Inhibition of the formation of vascular hyperpermeability |
| 05/17/2000 | EP1000936A1 Novel hexahydro-1,4-diazepine derivatives or salts thereof |
| 05/17/2000 | EP1000161A1 Anticoagulant fusion protein anchored to cell membrane |
| 05/17/2000 | EP1000087A2 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 05/17/2000 | EP1000084A1 123 human secreted proteins |
| 05/17/2000 | EP1000079A1 New formulation |
| 05/17/2000 | EP1000062A1 Tricyclic vasopressin agonists |
| 05/17/2000 | EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |